Showing items 1 - 3 of 3

Your selections:

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit